CM Life Sciences III Inc.

CM Life Sciences III Inc., which traded under the ticker EQRX, was a healthcare-focused blank-check company sponsored by CM Life Sciences, a partnership affiliated with Casdin Capital and Viking Global Investors. The SPAC completed its IPO in 2021 and later merged with EQRx, Inc., a biopharmaceutical company that aimed to develop and commercialize innovative medicines at lower cost. In November 2023, the company filed a Form 15-12G with the SEC, formally terminating its registration under the Exchange Act following EQRx's acquisition by Revolution Medicines, effectively closing out its run as a registered public entity. Visit SpacDesk and sign up for full filings, status history, and analytics on EQRX and every other SPAC in the market.